Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis

Table 1

Clinical characteristics for 23 patients.

Number of patients	23
Mean age	63.2 + 11
Gender (M/F)	15/8
Etiology (HBV/HCV/non-B-non-C/IPH)	1/14/6/2
Child-Pugh classification (A/B/C)	5/13/3
With or without HCC	12/9
Stage of HCC (I/II/III/IVA/IVB)	2/0/2/6/2

HCC: hepatocellular carcinoma.